Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-049242

President, R&D sold 25,000 shares at $30.00 ($750,000)

  • President, R&D acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-09-08 Option exercise +25,000 $4.12 $103,000 114,659 D
Bergstrom Donald A President, R&D 2022-09-08 Sale −25,000 $30.00 $750,000 89,659 D
Derivatives
Bergstrom Donald A President, R&D 2022-09-08 Option exercise · Stock Option (Right to Buy) −25,000 109,456 D
Open-market sales · 25,000 sh · avg $30.00 · $750,000
Loading xslF345X03/doc4.xml…